Schedule of roll forward of the level 3 valuation financial instruments |
|
|
|
For
the Year Ended
December 31, |
|
|
|
2020 |
|
|
2019 |
|
Balance at beginning of period |
|
$ |
890,410 |
|
|
$ |
- |
|
Initial valuation
of derivative liabilities included in debt discount |
|
|
85,502 |
|
|
|
320,351 |
|
Initial valuation of derivative
liabilities included in derivative expense |
|
|
160,416 |
|
|
|
516,634 |
|
Gain on extinguishment of
debt related to repayment/conversion of debt |
|
|
(1,066,535 |
) |
|
|
- |
|
Change in fair value included
in derivative expense |
|
|
(69,793 |
) |
|
|
53,425 |
|
Balance at end of period |
|
$ |
- |
|
|
$ |
890,410 |
|
|
Schedule of warranty liability |
|
|
For
the Nine Months Ended September 30, |
|
|
|
2021 |
|
|
2020 |
|
Balance at beginning of period |
|
$ |
26,833 |
|
|
$ |
26,933 |
|
Warranty costs incurred |
|
|
(100 |
) |
|
|
(100 |
) |
Balance at end of period |
|
$ |
26,733 |
|
|
$ |
26,833 |
|
|
|
|
For
the Year Ended December 31, |
|
|
|
2020 |
|
|
2019 |
|
Balance at beginning of period |
|
$ |
26,933 |
|
|
$ |
24,190 |
|
Increase in estimated warranty liability |
|
|
- |
|
|
|
4,650 |
|
Warranty expenses incurred |
|
|
(100 |
) |
|
|
(1,907 |
) |
Balance at end of period |
|
$ |
26,833 |
|
|
$ |
26,933 |
|
|
Schedule of diluted common shares outstanding |
|
|
September
30, |
|
|
|
2021 |
|
|
2020 |
|
Stock options |
|
|
8,445,698 |
|
|
|
8,445,698 |
|
Warrants |
|
|
1,000,000 |
|
|
|
2,050,000 |
|
Series B preferred stock |
|
|
114,598,413 |
|
|
|
17,142,857 |
|
Series C preferred stock |
|
|
298,412,698 |
|
|
|
100,000,000 |
|
Non-vested, forfeitable
common shares |
|
|
14,270,120 |
|
|
|
23,851,926 |
|
|
|
|
436,726,929 |
|
|
|
151,490,481 |
|
|
|
|
December 31,
2020 |
|
|
December 31,
2019 |
|
Convertible notes |
|
|
- |
|
|
|
14,333,333 |
|
Stock options |
|
|
8,445,698 |
|
|
|
8,445,698 |
|
Warrants |
|
|
2,050,000 |
|
|
|
2,050,000 |
|
Series A preferred stock |
|
|
- |
|
|
|
3,283,951 |
|
Series B preferred stock |
|
|
68,166,032 |
|
|
|
3,600,000 |
|
Series C preferred stock |
|
|
211,111,111 |
|
|
|
- |
|
Non-vested, forfeitable common shares |
|
|
23,826,926 |
|
|
|
17,475,299 |
|
|